HAL (France)open access
Landscape of new drugs and targets in inflammatory bowel disease
Phase 2, New drugs, 0, Inflammatory bowel disease, Clinical trials, Phase 3, Phase 1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 983869
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.